Latest News and Press Releases

Visiongain has published a new report entitled Retinal Gene Therapy Market Report 2024-2034: Forecasts by Approach (Gene Replacement, Gene Silencing, Gene Editing, Modifier Gene Therapy, Others), by...

Visiongain has published a new report entitled Specialty Pharma Market Report 2024-2034: Forecasts by Route of Administration (Oral, Parenteral, Rectal), by Distribution Channel (Hospitals, Retail...

Visiongain has published a new report entitled HIV Drugs and Injectables Market Report 2024-2034: Forecasts by Drug Class (Combination Therapies (Inclu. InSTI), NRTI & Non-NRTIs, Protease...

Visiongain has published a new report entitled Synthetic Biology Market Report 2024-2034: Forecasts by Product (Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic Cells,...

Visiongain has published a new report entitled Highly Potent Active Pharmaceutical Ingredients (HPAPIs) Market Report 2024-2034: Forecasts by Product (Synthetic, Biotech), by Manufacturer Type...

Visiongain has published a new report entitled CAR-T Therapy Market Report 2024-2034: Forecasts by Indication (Diffuse Large B-Cell Lymphoma (DLBCL), Acute Lymphoblastic Leukaemia (ALL), Follicular...

Visiongain has published a new report entitled Cancer Immunotherapy Market Report 2024-2034: Cancer Immunotherapy Market Report 2024-2034: Forecasts by Technology (Monoclonal Antibodies,...

Visiongain has published a new report entitled Biological Safety Testing Market Report 2024-2034: Forecasts by Products (Consumables, Instruments, Services & Others), by Application (Cellular...

Visiongain has published a new report entitled Synthetic Immunology Market Report 2024-2034: Forecasts by Type (Synthetic Antibodies, Synthetic Vaccines, Synthetic Adjuvants, Synthetic...

Visiongain has published a new report entitled Rare Diseases Market Report 2024-2034: Forecasts by Diseases (Cancer, Metabolic Diseases, Neurological Conditions, Hematologic Disorders, Infectious...